Advertisement

Topics

Researchers trace origins of AML relapse to rare therapy-resistant stem cells

22:15 EDT 28 Jun 2017 | News-Medical.net

Leukemia researchers led by Dr. John Dick have traced the origins of relapse in acute myeloid leukemia (AML) to rare therapy-resistant leukemia stem cells that are already present at diagnosis and before chemotherapy begins.

Original Article: Researchers trace origins of AML relapse to rare therapy-resistant stem cells

NEXT ARTICLE

More From BioPortfolio on "Researchers trace origins of AML relapse to rare therapy-resistant stem cells"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Leukemia
Leukemia is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts". Leukemia is a broad term covering a spectrum of diseases. In turn, it is part of the even broader grou...